Chemoinformaics analysis of [6] - isoshogaol
| Molecular Weight | 276.376 | nRot | 9 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 8 |
| Exact Molecular Weight | 276.173 | nRing | 1 |
| Solubility: LogS | -4.068 | nHRing | 0 |
| Solubility: LogP | 3.768 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 46.799 |
| nHD | 1 | BPOL | 26.681 |
| QED | 0.547 |
| Synth | 2.225 |
| Natural Product Likeliness | 1.481 |
| NR-PPAR-gamma | 0.765 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.875 |
| Pgp-sub | 0.007 |
| HIA | 0.004 |
| CACO-2 | -4.674 |
| MDCK | 0.0000214 |
| BBB | 0.35 |
| PPB | 0.980291 |
| VDSS | 0.554 |
| FU | 0.0121558 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.945 |
| CYP2c19-inh | 0.914 |
| CYP2c19-sub | 0.662 |
| CYP2c9-inh | 0.798 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.816 |
| CYP2d6-sub | 0.919 |
| CYP3a4-inh | 0.795 |
| CYP3a4-sub | 0.303 |
| CL | 11.157 |
| T12 | 0.886 |
| hERG | 0.079 |
| Ames | 0.044 |
| ROA | 0.374 |
| SkinSen | 0.956 |
| Carcinogencity | 0.589 |
| EI | 0.97 |
| Respiratory | 0.962 |
| NR-Aromatase | 0.477 |
| Antiviral | Yes |
| Prediction | 0.768288 |